IRIS Institutional Research Information System - AIR Archivio Istituzionale della Ricerca

PERSONENI, NICOLA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.225
EU - Europa 2.181
AS - Asia 1.763
SA - Sud America 184
AF - Africa 30
OC - Oceania 12
Continente sconosciuto - Info sul continente non disponibili 3
Totale 6.398
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.165
GB - Regno Unito 686
CN - Cina 555
SG - Singapore 548
DE - Germania 507
SE - Svezia 276
HK - Hong Kong 221
IT - Italia 176
RU - Federazione Russa 169
BR - Brasile 128
FR - Francia 109
VN - Vietnam 96
BD - Bangladesh 95
IE - Irlanda 71
IN - India 69
FI - Finlandia 46
NL - Olanda 36
CA - Canada 34
JP - Giappone 33
KR - Corea 29
UA - Ucraina 26
ID - Indonesia 24
TR - Turchia 22
AR - Argentina 19
DK - Danimarca 17
MX - Messico 12
EC - Ecuador 11
AU - Australia 10
IQ - Iraq 10
AT - Austria 9
BE - Belgio 9
CO - Colombia 8
ES - Italia 8
GR - Grecia 8
ZA - Sudafrica 8
PH - Filippine 7
PK - Pakistan 7
PY - Paraguay 6
JO - Giordania 5
MA - Marocco 5
NP - Nepal 5
RO - Romania 5
SA - Arabia Saudita 5
TW - Taiwan 5
UZ - Uzbekistan 5
VE - Venezuela 5
CI - Costa d'Avorio 4
BO - Bolivia 3
CH - Svizzera 3
CL - Cile 3
ET - Etiopia 3
JM - Giamaica 3
KE - Kenya 3
KZ - Kazakistan 3
PL - Polonia 3
TH - Thailandia 3
BA - Bosnia-Erzegovina 2
DO - Repubblica Dominicana 2
EG - Egitto 2
EU - Europa 2
GE - Georgia 2
GT - Guatemala 2
HR - Croazia 2
IL - Israele 2
IR - Iran 2
LB - Libano 2
MY - Malesia 2
NO - Norvegia 2
NZ - Nuova Zelanda 2
OM - Oman 2
PT - Portogallo 2
SK - Slovacchia (Repubblica Slovacca) 2
TN - Tunisia 2
AL - Albania 1
AN - Antille olandesi 1
AP - ???statistics.table.value.countryCode.AP??? 1
BB - Barbados 1
BG - Bulgaria 1
BZ - Belize 1
CR - Costa Rica 1
CZ - Repubblica Ceca 1
DZ - Algeria 1
GA - Gabon 1
GP - Guadalupe 1
HN - Honduras 1
HU - Ungheria 1
IM - Isola di Man 1
KG - Kirghizistan 1
KH - Cambogia 1
MK - Macedonia 1
MM - Myanmar 1
PE - Perù 1
RS - Serbia 1
SN - Senegal 1
SV - El Salvador 1
SY - Repubblica araba siriana 1
Totale 6.398
Salva come PNG Salva come JPEG
Città #
Southend 616
Frankfurt am Main 374
Singapore 297
Ashburn 247
Chandler 211
Hong Kong 203
Fairfield 155
Seattle 140
San Jose 135
Beijing 111
Wilmington 100
Princeton 81
Woodbridge 72
Dublin 71
Houston 69
Milan 63
Los Angeles 62
Council Bluffs 59
Dallas 49
New York 49
Ann Arbor 46
Lauterbourg 43
Nanjing 43
Cambridge 42
Moscow 35
Ho Chi Minh City 31
Santa Clara 31
Andover 30
Des Moines 30
Guangzhou 30
Buffalo 29
Bengaluru 26
Dearborn 25
Hanoi 25
Shanghai 23
Munich 21
Jakarta 20
Phoenix 20
Hefei 19
Helsinki 18
Tokyo 17
Columbus 16
Boardman 15
Redwood City 15
Chicago 14
Cangzhou 13
Toronto 13
Hangzhou 12
Shenyang 12
São Paulo 12
The Dalles 12
Tianjin 12
Eitensheim 11
San Diego 11
Bitonto 10
Changsha 10
Frederiksberg 10
Seoul 9
Silver Spring 9
Atlanta 8
Istanbul 8
Mountain View 8
Nuremberg 8
Brussels 7
Jinan 7
Rome 7
Zhengzhou 7
Brasília 6
Brooklyn 6
Hebei 6
Jiaxing 6
Montreal 6
Mumbai 6
Nanchang 6
Shenzhen 6
Belo Horizonte 5
Boston 5
Chennai 5
Denver 5
Guayaquil 5
Johannesburg 5
Kunming 5
Abidjan 4
Amman 4
Baghdad 4
Berlin 4
Da Nang 4
Dhaka 4
Fuzhou 4
London 4
Manila 4
Mexico City 4
Ningbo 4
Quanzhou 4
Quito 4
Tashkent 4
Amsterdam 3
Ankara 3
Asunción 3
Bologna 3
Totale 4.195
Salva come PNG Salva come JPEG
Nome #
KRAS mutation in lung metastases from colorectal cancer : Prognostic implications 312
Activity and safety of NGR-hTNF, a selective vascular-targeting agent, in previously treated patients with advanced hepatocellular carcinoma 284
Fatal Infusion Reaction to Cetuximab : The Need for Predictive Risk Factors and Safer Patient Selection 268
Derazantinib (ARQ 087) in advanced or inoperable FGFR2 gene fusion-positive intrahepatic cholangiocarcinoma. 265
ARQ 087, an oral pan- fibroblast growth factor receptor (FGFR) inhibitor, in patients (pts) with advanced and/or metastatic intrahepatic cholangiocarcinoma (iCCA) 255
Can stereotactic body radiation therapy be a viable and efficient therapeutic option for unresectable locally advanced pancreatic adenocarcinoma? Results of a phase 2 study 247
A randomized, multicenter, phase II study of vandetanib monotherapy versus vandetanib in combination with gemcitabine versus gemcitabine plus placebo in subjects with advanced biliary tract cancer : the VanGogh study 229
Tivantinib for second-line treatment of MET-high, advanced hepatocellular carcinoma (METIV-HCC): a final analysis of a phase 3, randomised, placebo-controlled study. 226
Tumor and circulating biomarkers in patients with second-line hepatocellular carcinoma from the randomized phase II study with tivantinib 221
A phase II randomized dose escalation trial of sorafenib in patients with advanced hepatocellular carcinoma 214
FOLFIRI and Cetuximab Every Second Week for First-Line Treatment of KRAS Wild-Type Metastatic Colorectal Cancer According to Phosphatase and Tensin Homolog Expression : a Phase II Study 212
Stereotactic Ablative Radiotherapy (SABR) in inoperable oligometastatic disease from colorectal cancer : a safe and effective approach 204
Diagnostic accuracy of 11C-choline PET/CT in comparison with CT and/or MRI in patients with hepatocellular carcinoma 202
Molecular determinants of outcome in sorafenib-treated patients with hepatocellular carcinoma 200
Prognostic value of the neutrophil-to-lymphocyte ratio in the ARQ 197-215 second-line study for advanced hepatocellular carcinoma 191
Standardisation of EGFR FISH in colorectal cancer: Results of an international interlaboratory reproducibility ring study 189
Achievements in systhemic therapies in the pre-genomic era in metastatic breast cancer 173
Usefulness of alpha-fetoprotein response in patients treated with sorafenib for advanced hepatocellular carcinoma 168
Assessment of HER2 status in patients with gastroesophageal adenocarcinoma treated with epirubicin-based chemotherapy: heterogeneity-related issues and prognostic implications 168
Epidermal growth factor receptor gene copy number in esophageal cancer and outcome prediction to gefitinib : does intratumoral heterogeneity matter? 168
Hepatocellular Carcinoma : A Global Disease in Need of Individualized Treatment Strategies 167
A Comparative Study of Methyl-BEAMing and Droplet Digital PCR for MGMT Gene Promoter Hypermethylation Detection 144
Clinical results of stereotactic body radiotherapy (SBRT) in the treatment of isolated local recurrence of pancreatic cancer after R0 surgery : a retrospective study 138
Tivantinib : a new promising mesenchymal–epithelial transition factor inhibitor in the treatment of hepatocellular carcinoma 136
Clinical Usefulness of EGFR Gene Copy Number as a Predictive Marker in Colorectal Cancer Patients Treated with Cetuximab : A Fluorescent In situ Hybridization Study 129
Advanced colorectal liver metastases and surgery after preoperative chemotherapy : is response-based selection enough? 127
Outcome prediction to erlotinib in gastroesophageal adenocarcinomas : can we improve epidermal growth factor receptor and phospho-AKT testing? 126
The role of hepatic metastases and pulmonary tumor burden in predicting survival after complete pulmonary resection for colorectal cancer 125
Tivantinib for second-line treatment of advanced hepatocellular carcinoma : a randomised, placebo-controlled phase 2 study 115
HER-2/neu amplification by fluorescence in situ hybridization in cytologic samples from distant metastatic sites of breast carcinoma 112
Phase III trial comparing protracted intravenous fluorouracil infusion alone or with yttrium-90 resin microspheres radioembolization for liver-limited metastatic colorectal cancer refractory to standard chemotherapy 111
Evaluation of HER-2/neu amplification and other biological markers as predictors of response to neoadjuvant anthracycline-based chemotherapy in primary breast cancer: the role of anthracycline dose intensity 104
Tivantinib for hepatocellular carcinoma 98
KRAS wild-type state predicts survival and is associated to early radiological response in metastatic colorectal cancer treated with cetuximab 98
Biomarkers in hepatocellular carcinoma - Letter 96
Hepatic intra-arterial injection of Yttrium-loaded microspheres for liver metastasis secondary to colorectal cancer: best soups are sometimes made from old recipes 95
Reply to Y. Pointreau et al 87
Correlation between the response to cetuximab alone or in combination with irinotecan and the activated/phosphorylated epidermal growth factor receptor in metastatic colorectal cancer 84
Sorafenib in Hepatitis C Virus-Negative Patients With Hepatocellular Carcinoma: Don't Throw the Baby Out With the Bathwater! 74
Interleukin-2 enhances the natural killer cell response to Herceptin-coated Her2/neu-positive breast cancer cells 72
Response prediction to EGFR-targeted therapies in colorectal cancer 67
null 3
Totale 6.704
Salva come PNG Salva come JPEG
Categoria #
all - tutte 17.907
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 17.907
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202162 0 0 0 0 0 0 0 0 0 0 0 62
2021/2022482 56 39 8 46 19 49 43 17 29 39 44 93
2022/2023619 91 105 74 72 48 109 3 35 37 14 25 6
2023/2024497 12 18 14 30 75 17 53 46 21 57 71 83
2024/20251.049 61 120 46 84 59 39 40 89 64 107 66 274
2025/20261.926 212 99 193 134 218 152 266 67 214 118 214 39
Totale 6.704